X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 94 filers reported holding X4 PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 2.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,000 | +125.0% | 15,805 | +452.4% | 0.00% | – |
| Q1 2024 | $4,000 | -87.9% | 2,861 | -92.7% | 0.00% | – |
| Q4 2023 | $33,000 | +65.0% | 39,321 | +117.9% | 0.00% | – |
| Q3 2023 | $20,000 | 0.0% | 18,043 | +76.1% | 0.00% | – |
| Q2 2023 | $20,000 | – | 10,243 | +10041.6% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 101 | -95.1% | 0.00% | – |
| Q2 2021 | $13,000 | -13.3% | 2,064 | +19.7% | 0.00% | – |
| Q1 2021 | $15,000 | +150.0% | 1,724 | +96.8% | 0.00% | – |
| Q4 2020 | $6,000 | – | 876 | +2725.8% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 31 | -69.6% | 0.00% | – |
| Q1 2020 | $1,000 | -90.0% | 102 | -89.0% | 0.00% | – |
| Q4 2019 | $10,000 | +233.3% | 930 | +241.9% | 0.00% | – |
| Q3 2019 | $3,000 | – | 272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 2,300,315 | $4,462,611 | 4.69% |
| Stonepine Capital Management, LLC | 4,605,263 | $8,934,210 | 3.22% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $30,963,541 | 3.19% |
| Tri Locum Partners LP | 4,099,943 | $7,953,889 | 2.96% |
| NEA Management Company, LLC | 14,986,793 | $29,074,378 | 2.22% |
| Lynwood Capital Management Inc. | 525,000 | $1,018,500 | 1.29% |
| Parkman Healthcare Partners LLC | 3,766,593 | $7,307,190 | 1.27% |
| Sio Capital Management, LLC | 1,749,003 | $3,393,066 | 0.86% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $649,900 | 0.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $3,828,945 | 0.36% |